RiDYMO® Designs Cyclic Peptide for “Undruggable” β-Catenin Target Within Two Months 
Oncolytics Biotech(R) Announces Exercise of Warrants
SAN DIEGO, CA and CALGARY, AB / ACCESSWIRE / November 12, 2019 / Oncolytics Biotech® Inc. (NASDAQ:ONCY) (TSX:ONC), currently developing...
Hologic Announces FDA Approval of 3DQuorum™ Imaging Technology, Powered by Genius AI™
Breakthrough Artificial Intelligence-powered algorithm significantly reduces mammography exam read times without compromising image quality, sensitivity or accuracy1,2 MARLBOROUGH, Mass.--(BUSINESS WIRE)--#3DGenius--Hologic,...
InVivo Therapeutics Announces Appointment of Robert Rosenthal to Board of Directors
CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV) today announced the appointment of Robert J. Rosenthal, Ph.D., to the Company’s Board...
eClinicalWorks & healow Announce Collaboration With Humana, GuideWell, & Trusted Health Plan
The collaboration will provide advanced bidirectional interoperability solutions for providers, payers, and patients through its healow Insights integrated services WESTBOROUGH,...
Medsphere Deepens Relationship with Saipan’s Commonwealth Healthcare, Plans CareVue EHR/RCM Implementation
Relationship expands from supporting existing system on Northern Mariana Islands to installing more functionally rich, expandable healthcare IT platform SAIPAN,...
Dynatronics Reports First Quarter Results for Fiscal 2020
COTTONWOOD HEIGHTS, UT / ACCESSWIRE / November 12, 2019 / Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy,...
Hemogenyx Pharmaceuticals PLC Announces Presentation at the Investival Showcase
LONDON, UK / ACCESSWIRE / November 12, 2019 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and...
Evotec SE Reports First Nine-Month 2019 Results and Corporate Updates
INITIATION OF MULTIPLE NEW PARTNERSHIPS AND IMPORTANT EXTENSIONS; VERY GOOD PROGRESS IN CO-OWNED PIPELINE 16% INCREASE IN GROUP REVENUES, 36%...
CONMED Corporation to Present at the Jefferies London Healthcare Conference
UTICA, N.Y.--(BUSINESS WIRE)--CONMED Corporation (NASDAQ: CNMD) today announced that Todd W. Garner, Executive Vice President and Chief Financial Officer, will...
Kadmon Announces that KD025 Met Primary Endpoint at Interim Analysis of Pivotal Trial in Chronic Graft-Versus-Host Disease
KD025 Achieved ORRs of 64% with KD025 200 mg QD and 67% with KD025 200 mg BID Conference Call Today...
Results for Bimagrumab in Obesity and Type 2 Diabetes Presented by MorphoSys’s Partner
PLANEGG/MUNICH, GERMANY / ACCESSWIRE / November 11, 2019 / MorphoSys AG (FSE: MOR; Prime Standard Segment; MDAX & TecDAX; NASDAQ:...
ReShape Lifesciences Announces 1-for-120 Reverse Stock Split
SAN CLEMENTE, CA / ACCESSWIRE / November 11, 2019 / ReShape Lifesciences Inc. (OTCQB:RSLS), a developer of minimally invasive medical...
Indo Global Exchange(s) Pte Ltd Provides Shareholder Update
CLOVERDALE, CA / ACCESSWIRE / November 11, 2019 / Indo Global Exchange(s) Pte Ltd (OTC PINK:IGEX) is pleased to update...
XPhyto Therapeutics Oral and Transdermal Cannabis Delivery and Dosage Systems
VANCOUVER, BC / ACCESSWIRE / November 11, 2019 / XPhyto Therapeutics Corp. (CSE:XPHY; FSE:4XT) ("XPhyto" or the "Company") is pleased...
Heat Biologics Presents Additional Phase 2 Interim Data in Advanced NSCLC Patients at the SITC 34th Annual Meeting
Promising results in patients whose disease has progressed after checkpoint inhibitor therapy DURHAM, NC / ACCESSWIRE / November 11, 2019...
Aytu BioScience Announces Hiring of Matthew Phillips as Executive Vice President of Commercial Operations
ENGLEWOOD, CO / ACCESSWIRE / November 11, 2019 / Aytu BioScience, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on global...
Newly Published Research Demonstrates Ability of Hologic’s Assay to Detect Mycoplasma Genitalium, “the Silent Epidemic”
– First FDA-cleared test for this sexually transmitted bacterium can lead to earlier detection and appropriate treatment – MARLBOROUGH, Mass.--(BUSINESS...
Pulse8 Presenting as a Panelist on Provider-Health Plan Relationships During the RISE Risk Adjustment Forum in Scottsdale, AZ
CHICAGO--(BUSINESS WIRE)--In its 14th year, the annual RISE Risk Adjustment Forum acts as a resource for health professionals seeking expert...
Motus GI Announces EXPEDITE Study Initiated by Boston Medical Center to Evaluate Clinical Effectiveness of Pure-Vu® System for Improving Bowel Preparation Rates
Investigator-Initiated study will assess the ability of the Pure-Vu System to accelerate time to a successful colonoscopy in a real-world...
Thousands of Healthcare Professionals Convene in Orlando for NextGen Healthcare Annual Conference
UGM 2019 features 200 educational sessions to help empower attendees to transform ambulatory care in their communities IRVINE, Calif.--(BUSINESS WIRE)--#Believeinbetter--NextGen...